Back to companies

IMMUNIC, INC.

IMUXUSNASDAQPharmaceuticals & Healthcare

IMMUNIC, INC.

Revenue
—
FY2025
Operating income
-$103.2mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API